Abstract
Performance specifications for automated prescreening devices for cervical cancer will concern rates for missed positive samples and rates for false alarms. Testing whether a given device adheres to such specifications within given confidence limits should be feasible for the missed positive rates. The test for adherence to the specified false alarm rate presents a serious sampling problem.